These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21630390)

  • 21. Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase.
    Rodríguez-Franco MI; Fernández-Bachiller MI; Pérez C; Castro A; Martínez A
    Bioorg Med Chem; 2005 Dec; 13(24):6795-802. PubMed ID: 16183292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoenzymatic synthesis of (+)-alpha-polypodatetraene and methyl (5R,10R,13R)-labda-8-en-15-oate.
    Kinoshita M; Miyake T; Arima Y; Oguma M; Akita H
    Chem Pharm Bull (Tokyo); 2008 Jan; 56(1):118-23. PubMed ID: 18175991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
    Grigoryan HA; Hambardzumyan AA; Mkrtchyan MV; Topuzyan VO; Halebyan GP; Asatryan RS
    Chem Biol Interact; 2008 Jan; 171(1):108-16. PubMed ID: 17980356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Huang L; Luo Z; He F; Lu J; Li X
    Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
    Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
    J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
    Tasso B; Catto M; Nicolotti O; Novelli F; Tonelli M; Giangreco I; Pisani L; Sparatore A; Boido V; Carotti A; Sparatore F
    Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-reactivity probes for active site shapes of cholesterol esterase by carbamate inhibitors.
    Lin G; Shieh CT; Tsai YC; Hwang CI; Lu CP; Chen GH
    Biochim Biophys Acta; 1999 May; 1431(2):500-11. PubMed ID: 10350625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
    Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
    Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of amino acid residues involved in the binding of Huperzine A to cholinesterases.
    Saxena A; Qian N; Kovach IM; Kozikowski AP; Pang YP; Vellom DC; Radić Z; Quinn D; Taylor P; Doctor BP
    Protein Sci; 1994 Oct; 3(10):1770-8. PubMed ID: 7849595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipase-catalyzed resolution of (2R*,3S*)- and (2R*,3R*)-3-methyl-3-phenyl-2-aziridinemethanol at low temperatures and determination of the absolute configurations of the four stereoisomers.
    Sakai T; Liu Y; Ohta H; Korenaga T; Ema T
    J Org Chem; 2005 Feb; 70(4):1369-75. PubMed ID: 15704972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lipase-catalyzed kinetic resolution of 2-substituted cycloalkanols].
    Forró E
    Acta Pharm Hung; 2001; 71(1):119-26. PubMed ID: 11769092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective inhibition of butyrylcholinesterase by singlet oxygen-generated melatonin derivatives.
    Moleda Z; Wojtasiewicz K; Panasiewicz M; Czarnocki Z
    J Pineal Res; 2010 Aug; 49(1):55-9. PubMed ID: 20459459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of a new series of tri-, di-, and mono-N-alkylcarbamylphloroglucinols as bulky inhibitors of acetylcholinesterase.
    Lin MC; Lin GZ; Shen YF; Jian SY; Hsieh DK; Lin J; Lin G
    Chem Res Toxicol; 2012 Jul; 25(7):1462-71. PubMed ID: 22690874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-Aryl-4-oxo-N-phenyl-2-aminylbutyramides as acetyl- and butyrylcholinesterase inhibitors. Preparation, anticholinesterase activity, docking study, and 3D structure-activity relationship based on molecular interaction fields.
    Vitorović-Todorović MD; Juranić IO; Mandić LM; Drakulić BJ
    Bioorg Med Chem; 2010 Feb; 18(3):1181-93. PubMed ID: 20061157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine.
    Luo W; Yu QS; Zhan M; Parrish D; Deschamps JR; Kulkarni SS; Holloway HW; Alley GM; Lahiri DK; Brossi A; Greig NH
    J Med Chem; 2005 Feb; 48(4):986-94. PubMed ID: 15715468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of organophosphates with fluorine-containing leaving groups as serine esterase inhibitors with potential for Alzheimer disease therapeutics.
    Makhaeva GF; Aksinenko AY; Sokolov VB; Serebryakova OG; Richardson RJ
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5528-30. PubMed ID: 19717305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-Phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors: a study on the importance of modifications at the side chain on the activity.
    Shen Y; Sheng R; Zhang J; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2008 Aug; 16(16):7646-53. PubMed ID: 18662884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopaminergic (4aR,10bS)-cis- and (4aS,10bS)-trans-octahydrobenzo[F]quinolines have similar pharmacophores.
    Froimowitz M; Deng Y; Jacob JN; Li N; Cody V
    Drug Des Discov; 1995 Aug; 13(1):73-81. PubMed ID: 8882902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.